Metabolomics-derived biomarkers for biosafety assessment of Gd-based nanoparticle magnetic resonance imaging contrast agents-Reference-Cited by-同舟云学术

Metabolomics-derived biomarkers for biosafety assessment of Gd-based nanoparticle magnetic resonance imaging contrast agents

Published:2024 Issue: Volume: Page:
ISSN:0003-2654
Container-title:The Analyst
language:en
Short-container-title:Analyst

Author:

Xu Chen¹²,Sun Jie³,Zhang Chenhao¹,Yang Lu¹,Kan Hong¹²^ORCID,Zhang Daguang⁴,Xue Guan⁴,Dong Kai¹²^ORCID

Affiliation:

1. College of Chinese Medicinal Materials, Jilin Agricultural University, 2888 Xincheng Street, Changchun 130118, Jilin, China

2. National & Local Joint Engineering Research Center for Ginseng Breeding and Development, Changchun 130118, China

3. School of Chemical Engineering, Changchun University of Technology, Changchun 130012, China

4. Department of Orthopaedics, The First Hospital of Jilin University, Changchun 130021, China

Abstract

We employed an ultra-high performance liquid chromatography–electrospray ionization quadrupole time-of-flight mass spectrometry-based metabolomics approach to investigate the potential toxicity of Gd-based nanoparticle MRI contrast agents.

Funder

National Natural Science Foundation of China

Jilin Provincial Scientific and Technological Development Program

Publisher

Royal Society of Chemistry (RSC)

Subject

Electrochemistry,Spectroscopy,Environmental Chemistry,Biochemistry,Analytical Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2024/AN/D3AN01641B

Reference43 articles.

1. Chemistry of MRI Contrast Agents: Current Challenges and New Frontiers

2. Molecular imaging nanoprobes for theranostic applications

3. Paramagnetic and Superparamagnetic Inorganic Nanoparticles for T1-Weighted Magnetic Resonance Imaging

4. A Comprehensive Updated Review on Magnetic Nanoparticles in Diagnostics